|
- Home Page - Cypre
Cypre builds immune and stroma competent organoids that aim to recreate the complexity of disease in a standardized and high throughput screening format
- Homepage - Cypress College
Unlawful Discrimination, Harassment and Sexual Assault Misconduct ©2020 Cypress College 9200 Valley View Street, Cypress, CA 90630 (714) 484-7000 Cypress College is part of the North Orange County Community College District and is accredited by the Accrediting Commission for Community and Junior Colleges
- Resources - Cypre
Cypre co-presented a webinar with Charles River titled “Predict Anticancer Efficacy with a New In Vitro 3D Modeling Platform” The webinar is now available on-demand through the link below
- News Events - Cypre
Cypre announces its 3D in vitro tumor models services and landmark publication detailing the platform for screening targeted and immunotherapy compounds and assessing novel immuno-modulatory insights
- Platform - Cypre
Cypre Organoid Platform Human-derived tumor microenvironment organoids (TMOs) integrating immune and stromal compartments — built for MOA insights Tumor-stroma-immune in the Cypre Organoid Platform
- Cypre | What we do | Home - bp
The Cypre project was pleased to announce the successful completion of its Phase 1 startup in the first quarter of 2025, marking a significant step forward in the development of this world-class energy asset
- Cypre - Crunchbase Company Profile Funding
Cypre Inc is a biotechnology company developing novel 3D in vitro models of the tumor microenvironment (TME) for cancer drug discovery
- Cypre Inc. - BIO International Convention 2025
Cypre builds next-generation tumor organoids that decode immune and stromal response for oncology drug development Our immune-integrated platform combines human tumor, fibroblast, and immune cells to model complex tumor microenvironment biology – enabling high-content phenotypic screening, MOA discovery, and immune-modulated response analytics
|
|
|